Summit Global Investments Incyte Corp Transaction History

Summit Global Investments

$1.34 Billion
Q1 2024

A detailed history of Summit Global Investments transactions in Incyte Corp stock. As of the latest transaction made, Summit Global Investments holds 104,210 shares of INCY stock, worth $6.32 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

104,210

Previous 69,006 51.02%

Holding current value

$6.32 Million

Previous $4.33 Million 37.02%

% of portfolio

0.44%

Previous 0.28%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$56.55 - $66.59 $1.99 Million - $2.34 Million	35,204 Added 51.02%	104,210 $5.94 Million
Q4 2023 Feb 06, 2024	SELL	$52.16 - $64.19 $561,919 - $691,518	-10,773 Reduced 13.5%	69,006 $4.33 Million
Q3 2023 Oct 13, 2023	SELL	$57.77 - $65.93 $8.51 Million - $9.71 Million	-147,279 Reduced 64.86%	79,779 $4.61 Million
Q2 2023 Jul 18, 2023	SELL	$60.95 - $75.51 $973,920 - $1.21 Million	-15,979 Reduced 6.57%	227,058 $14.1 Million
Q1 2023 May 04, 2023	BUY	$70.23 - $86.01 $220,100 - $269,555	3,134 Added 1.31%	243,037 $17.6 Million

Q4 2022 Jan 31, 2023	SELL	$67.18 - $84.11 $441,171 - $552,350	-6,567 Reduced 2.66%	239,903 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $572,192 - $716,407	8,646 Added 3.64%	246,470 $16.4 Million
Q2 2022 Aug 23, 2022	BUY	$66.18 - $83.18 $3.57 Million - $4.49 Million	53,953 Added 29.34%	237,824 $18.1 Million
Q1 2022 Apr 29, 2022	BUY	$66.02 - $79.71 $9.79 Million - $11.8 Million	148,270 Added 416.48%	183,871 $14.6 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $9.26 Million - $10.8 Million	-146,119 Reduced 80.41%	35,601 $2.61 Million
Q3 2021 Nov 08, 2021	BUY	$68.67 - $84.02 $6.94 Million - $8.49 Million	101,081 Added 125.35%	181,720 $12.5 Million
Q2 2021 Jan 28, 2022	BUY	$79.87 - $87.53 $1.45 Million - $1.59 Million	18,182 Added 29.11%	80,639 $6.79 Million
Q1 2021 Jan 27, 2022	BUY	$76.02 - $100.5 $392,187 - $518,479	5,159 Added 9.0%	62,457 $5.08 Million
Q4 2020 Feb 11, 2021	SELL	$80.74 - $97.7 $365,671 - $442,483	-4,529 Reduced 7.33%	57,298 $4.98 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $2,467 - $3,181	-29 Reduced 0.05%	61,827 $5.55 Million
Q2 2020 Aug 11, 2020	BUY	$74.18 - $108.93 $4.59 Million - $6.74 Million	61,856 New	61,856 $6.43 Million

Others Institutions Holding INCY

# of Institutions

617

Shares Held

215M

Call Options Held

366K

Put Options Held

445K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Account

Summit Global Investments Incyte Corp Transaction History